KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elevance Health (ELV) Enterprise Value (2016 - 2025)

Elevance Health (ELV) has disclosed Enterprise Value for 17 consecutive years, with -$34.9 billion as the latest value for Q3 2025.

  • On a quarterly basis, Enterprise Value fell 292.87% to -$34.9 billion in Q3 2025 year-over-year; TTM through Dec 2025 was -$53.6 billion, a 60.48% decrease, with the full-year FY2024 number at -$33.4 billion, down 401.47% from a year prior.
  • Enterprise Value was -$34.9 billion for Q3 2025 at Elevance Health, down from -$33.7 billion in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of $71.0 million in Q3 2021 to a low of -$37.9 billion in Q2 2023.
  • A 5-year average of -$17.9 billion and a median of -$10.3 billion in 2022 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: soared 101.78% in 2021, then crashed 49264.29% in 2023.
  • Elevance Health's Enterprise Value stood at -$6.7 billion in 2021, then decreased by 23.31% to -$8.3 billion in 2022, then rose by 19.35% to -$6.7 billion in 2023, then plummeted by 401.47% to -$33.4 billion in 2024, then decreased by 4.46% to -$34.9 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Enterprise Value are -$34.9 billion (Q3 2025), -$33.7 billion (Q2 2025), and -$32.8 billion (Q1 2025).